INCR
Intercure Ltd.
$1.13
+0.03 (+2.73%)
Institutional flow:
-17% holders QoQ · +1 funds added
Short interest:
0.08% of float · ▲ +72.6% MoM · 1.0 days cover
Institution breadth:
15 holders — near 3-yr low, contrarian setup
2 Up Days
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.13
Open$1.10
Day$1.09–1.14
52W$0.68–1.77
Avg vol 30d75K
Short int47K · 1.0d
Short vol1%
Last earningsDec 31, 2022
DataJan 2020–Jul 2026
Equibles Rating
blended score
Overall
Neutral
Technical · trend & momentum
Buy
+
Price vs 200-day avg · +4% above
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+4% above
+
Price vs 50-day avg
+22% above
◦
RSI (14)
64 · neutral
+
MACD trend
positive
◦
52-week position
41% · mid-range
Sentiment · smart money
Bearish
−
Institutional flow · -17% holders QoQ · +1 funds added
◦
Trend (MA cross)
50d $1 › 200d $1 — 200d above 50d
−
Institutional flow
-17% holders QoQ · +1 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.08% of float · ▲ +72.6% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
15 holders — near 3-yr low, contrarian setup
Fundamentals
Limited data
Not enough data for a confident read
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$64.58M
Shares
57,152,396
CIK
1857030
CUSIP
M549GJ111
Website
Visit website
Investor Relations
Investor relations
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+4% above
Bullish
Price vs 50-day avg
+22% above
Bullish
RSI (14)
64 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
41% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-17% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.08% of float · ▲ +72.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
15 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $1 · 41%
52-wk high $2
vs 200-day avg +4%
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INCR
this stock
Intercure Ltd.
|
$64.58M | +24.2% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$53.33B | +9.7% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.35B | -7.7% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
15
- % held
- 1.1%
- Net QoQ
- -118.3K sh
- Top holder
- HEALTHCARE OF ONTARIO PEN…
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INCR | +13.0% | +9.7% | +20.2% | +2.7% | +24.2% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | +11.2% | +11.3% | +12.3% | +4.0% | +14.7% |